Delivery Order SPE2DB22D1106-SPE2DB24FFLR4

Award Date 9/9/24
Potential Completion Date 9/10/24
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $17,156.46 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The $4,123.94 firm fixed-price contract has an ultimate completion date of April 2, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
The Defense Logistics Agency (DLA) awarded a $5,673.04 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 2.4 mg/0.75 ml pens. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $3,324.85 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML medication. The contract has a period of performance through May 14, 2025 and is not set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 1 MG/0.5 ML PEN 0.5ML. The $12,285.00 contract has an ultimate completion date of January 30, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a ceiling value of $10,821.72 and a period of performance through January 3, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of WEGOVY 1 MG/0.5 ML PEN 0.5ML pharmaceutical products. The $1,097.08 contract has a completion date of February 21, 2024. AmerisourceBergen Drug Corp has previously received numerous DLA contracts to provide pharmaceuticals, medical supplies, and related distribution services in support of military treatment programs...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,095.00 firm fixed-price delivery order is for the supply of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract has an ultimate completion date of May 9, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a $41,692.55 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to deliver a wide range of medical commodities and pharmaceuticals in support of military treatment programs and facilities worldwide....
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The contract is for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product, with a potential value of $1,344.53 and a completion date of February 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFLR4
    Delivery Order

The Defense Logistics Agency (DLA) has awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 1 MG/0.5 ML PEN 0.5ML. This $19,284.13 firm fixed price contract has a completion date of September 10, 2024. AmerisourceBergen holds a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, to provide a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation. This award is part of AmerisourceBergen's extensive federal contracting portfolio, which includes supplying critical care materials and pharmaceuticals to various government agencies and healthcare programs.

Generated 12/9/24, 1:43 PM